Barrett Esophagus-II: Clinical Manifestations and Management
Assessment of the Rectum and Anus
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease IV: Pharmacological Management
Inflammatory Bowel Disease I: Ulcerative Colitis
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Xiao-Jun Ren1, Ming-Hong Lei2, Ying-Xia Cheng3
1Department of Gastroenterology & Hepatology, Dazhou Integrated TCM and Western Medicine Hospital: Dazhou Second People's Hospital, Dazhou, Sichuan, China.
奥西默提尼布是治疗非小细胞肺癌 (NSCLC) 的药物,可能会导致胃肠道出血. 停止使用这种EGFR抑制剂导致症状消失,这表明患者存在潜在风险.
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: